Lifevantage Corporation · NASDAQ:LFVN

Lifevantage — Investor Presentation (April 2008)

24 slides from Lifevantage's investor presentation, Apr 11, 2008

  1. Slide 1: Investor Presentation April 2008

    Investor Presentation April, 2008 www.LifeVantage.com Trading Symbol on OTCBB: LFVN (tm)

  2. Slide 2: Forward-looking statements

    Statements in this presentation which are not statements of historical fact are "forward-looking statements" within the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on information available to, and the expectations and assu

  3. Slide 3: Cash Flow Positive in First Six Months of FY 2008

    $100K Cash Flow Positive in First Six Months of FY 2008 Q1/Q2 FY08: First Quarters of Increasing Cash Flow From Operations since 2005 Expenses Drastically Reduced * In Thousands ** Fiscal Year Ends June 30

  4. Slide 4: New CEO and Management Team In Place

    New CEO and Management Team In Place Strong Product in High Growth Segment Aggressive Pursuit of New Sales Channels Rollout of Direct Response Commercials Targeted Advertising Substantial International Licensing Agreement Announced in February.

  5. Slide 5: David Brown, CEO

    David Brown, CEO Seasoned Industry Veteran-Hired January '08 CEO & President, Metabolife International Transitioned leading dietary supplement company from direct sales to retail channels President, Natural Balance, Inc. Directed expansion from health food channels to mass-market retail Revenue grow

  6. Slide 6: Peter Baloff, Marketing; Jan Strode, Corporate Communications

    Peter Baloff, Marketing Authority on health/nutrition marketing Produced over 200 commercials: Princess Cruises, Hallmark, Universal Pictures, Capital Records Natural Products: Jenny Craig, Bally Total Fitness, Natural Balance, Interior Design (Nu-Skin) Jan Strode, Corporate Communications Firestone

  7. Slide 7: Aging progresses slowly when we're young

    ....because a young body defends itself more efficiently by creating ample amounts of antioxidants to neutralize most of the free-radicals produced in the body. AGING progresses slowly when we're young...

  8. Slide 8: As we grow older the aging process progresses rapidly

    As we grow older the AGING process progresses rapidly

  9. Slide 9: Aging is your body's way of rusting from the inside out

    In a sense, aging is your body's way of rusting from the inside out.

  10. Slide 10: Free-radical damage called Oxidative Stress

    This free- radical damage that causes aging is called Oxidative Stress

  11. Slide 11: Clinically proven, patented dietary supplement

    Clinically proven, patented dietary supplement Increases the body's natural antioxidant protection at the cellular level

  12. Slide 12: Oxidative damage measured by TBARS increases with age

    AGE Oxidative damage caused by free radicals can be measured by the amount of toxins they produce. Those toxins are called TBARS and increase with age. TBARS (micromolar)

  13. Slide 13: Traditional antioxidant supplements do not affect oxidative damage

    In a peer reviewed, published, human medical study, the amount of oxidative damage (TBARS) was measured in control subjects of all ages, many of whom were taking antioxidant supplements. antioxidant supplements As shown, traditional antioxidant supplements in normal healthy humans do not affect the

  14. Slide 14: Protandim significantly decreases TBARS

    Subjects who take Protandim for 30 days show significant decrease in TBARS Among control subjects of all ages, the acceleration of aging as measured by the amount of oxidative damage (TBARS) has been reduced to the level of a 20 year old.

  15. Slide 15: Anti-aging market size

    Anti-aging supplements (about $5 billion)* Anti-aging services and related products (about $50 billion)** Other cosmetic products such as make-up (about $50 billion)*** Exercise equipment (about $5 billion)**** *2005, Nutrition Business Journal **, 2007,Business Communications Co. ***2006,Euromonito

  16. Slide 16: Independent studies underway and patent barrier to entry

    Over 20 Independent Human Clinical and Lab Studies Underway at Leading Institutions Including: University of Colorado Denver Health Medical Center Children's Hospital, Denver University of Florida University of Kentucky University of Michigan Louisiana State University Existing & Future Research Ens

  17. Slide 17: Sales & Marketing: Driving New Growth

    LirEVANTAGE Sales & Marketing: Driving New Growth tandim

  18. Slide 18: Japan: Nutranomics

    Japan: Nutranomics Nutranomics: Leading US-based distributor into Japan; veteran of successful product launches in Asian market Manufacture & MLM with in-country strategic partner Manufacture product to precise Protandim(r) standards Push product under their brand name in Japan through distributors

  19. Slide 19: June 2005 Primetime Live piece on Protandim

    June 2005: 6-Minute Piece on Protandim(r) Aired on Primetime Live Resulted in large sales volume, despite no direct call to action to customer call to action to customer call to action to customer call to action to customer call to action to customer

  20. Slide 20: Direct response commercials directed by Peter Baloff

    Directed by award-winning Peter Baloff Expectation: Direct Response with strong call to action will drive large sales volume at low customer acquisition costs. acquisition costs. acquisition costs. acquisition costs. acquisition costs.

  21. Slide 21: Retail Channel: Optimize & Expand

    Retail Channel: Optimize & Expand Existing Channels: Strong avenues in place (GNC, Vitamin Cottage, Others) Increase in-store promotion and education New Channels: New CEO has strong contacts at major retailers Goal: Market penetration into major health food retailers SuperSupplements

  22. Slide 22: Web Initiatives

    Web Initiatives: Increased web traffic through affiliates & SEO Change look & appeal of website for increased conversion

  23. Slide 23: Comparison with Sirtris Pharmaceuticals

    Sirtris Pharmaceuticals (NASDAQ: SIRT) $330 Million Market Cap R&D Stage Company Resveratrol-based antioxidant solution LifeVantage (OTCBB: LFVN) Aggressive & Experienced New Management Patents & Clinical Data Historical Revenue & High Growth Strategy $7 Million Market Cap $7 Million Market Cap $7 M

  24. Slide 24: Thank You

    www.LifeVantage.com LFVN.OB Jan Strode janstrode@aol.com 619-223-9915 Thank You (tm)

LifeVantage — Investor Presentation (April 2008) on 6ix